Biolojic Design
Biolojic Design is redefining what antibodies can do.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Biolojic Design is a company that leverages its platform to engineer epitope specific antibodies and multibodies, using machine learning to program antibodies as dynamic functional switches. Their AI-designed antibodies aim to provide precise molecular effects in the desired micro-environment, leading to greater efficacy and lower toxicity.
History
Biolojic Design is a company that leverages its platform to engineer epitope specific antibodies and multibodies. Using machine learning, they create drugs by programming antibodies to become dynamic functional switches. Their AI-designed antibodies provide a precise molecular effect in the desired micro-environment, at the right time, leading to greater efficacy and lower toxicity.
Recent events
- Unconfirmed
Reported
Lilly and Biolojic Design sign diabetes therapy research collaboration[2]
Eli Lilly and Biolojic Design signed a research collaboration and license agreement to discover and develop an antibody-based therapy for diabetes. Lilly will use Biolojic’s AI-based platform to discover a multi-specific antibody.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/biolojic-design · Editorial policy · How profiles are compiled